Fennec Pharmaceuticals (FENC) Net Equity Issued and Repurchased (2013 - 2020)

Fennec Pharmaceuticals' Net Equity Issued and Repurchased history runs 7 years deep, the most recent figure standing at $32.0 million for Q2 2020.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $32.0 million in Q2 2020, while the trailing twelve-month figure through Dec 2020 was $32.0 million (changed N/A YoY) and the FY2020 annual result came in at $32.0 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased was $32.0 million for Q2 2020 at Fennec Pharmaceuticals, up from -$1.1 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $32.0 million in Q2 2020 and bottomed at -$1.1 million in Q4 2018.
• A 4-year average of $5.8 million and a median of $383000.0 in 2017 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2017 — Net Equity Issued and Repurchased jumped 1533.33% — and 2018, when it plunged 104.25%.
• Fennec Pharmaceuticals' Net Equity Issued and Repurchased stood at $4.9 million in 2016, then surged by 449.24% to $26.9 million in 2017, then plunged by 104.25% to -$1.1 million in 2018, then soared by 2899.21% to $32.0 million in 2020.
• Business Quant data shows FENC's Net Equity Issued and Repurchased at $32.0 million in Q2 2020, -$1.1 million in Q4 2018, and $483000.0 in Q3 2018.